[1]
2022. Barriers to access to medicines for noncommunicable diseases for patients using the Brazilian Unified Health System (SUS). Brazilian Journal of Pharmaceutical Sciences. 57, (Nov. 2022). DOI:https://doi.org/10.1590/s2175-979020200001181016.